Matrana, M. R., Bathala, T., Campbell, M. T., Duran, C., Shetty, A., Teegavarapu, P., . . . Tannir, N. M. (2015). Outcomes of Unselected Patients with Metastatic Clear-Cell Renal Cell Carcinoma Treated with Front-Line Pazopanib Therapy Followed by Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitors (VEGFR-TKI) or Mammalian Target of Rapamycin Inhibitors (mTORi): A Single Institution Experience. BJU Int.
Style de citation ChicagoMatrana, Marc R., et al. "Outcomes of Unselected Patients With Metastatic Clear-Cell Renal Cell Carcinoma Treated With Front-Line Pazopanib Therapy Followed By Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitors (VEGFR-TKI) or Mammalian Target of Rapamycin Inhibitors (mTORi): A Single Institution Experience." BJU Int 2015.
Style de citation MLAMatrana, Marc R., et al. "Outcomes of Unselected Patients With Metastatic Clear-Cell Renal Cell Carcinoma Treated With Front-Line Pazopanib Therapy Followed By Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitors (VEGFR-TKI) or Mammalian Target of Rapamycin Inhibitors (mTORi): A Single Institution Experience." BJU Int 2015.